<bill session="118" type="h" number="3810" updated="2025-05-27T14:12:59Z">
  <state datetime="2023-06-05">REFERRED</state>
  <status>
    <introduced datetime="2023-06-05"/>
  </status>
  <introduced datetime="2023-06-05"/>
  <titles>
    <title type="display">Drug Origin Transparency Act of 2023</title>
    <title type="short" as="introduced">Drug Origin Transparency Act of 2023</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="E000215"/>
  <cosponsors>
    <cosponsor bioguide_id="C001119" joined="2023-07-11"/>
    <cosponsor bioguide_id="C001097" joined="2023-09-13"/>
    <cosponsor bioguide_id="P000608" joined="2023-07-25"/>
    <cosponsor bioguide_id="S001168" joined="2023-07-11"/>
  </cosponsors>
  <actions>
    <action datetime="2023-06-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-06-05" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2023-06-09">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="4697" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Consumer affairs"/>
    <term name="Government information and archives"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2024-06-28T20:20:10Z" status="Introduced in House">Drug Origin Transparency Act of 2023&#160;

This bill requires drug manufacturers to report on the suppliers of ingredients used in their products.

Specifically, drug manufacturers must report information relating to the supply chain of their products, including the suppliers of active ingredients and the amount of drugs that are manufactured using those ingredients. Drug manufacturers must also include information about the manufacturers of ingredients on the labels of their products.</summary>
</bill>
